Document is current
Any future updates will be listed below
-
Authors
Gangishetti, Umesh
Christina Howell, J.
Perrin, Richard J.
Louneva, Natalia
Watts, Kelly D.
Kollhoff, Alexander
Grossman, Murray
Wolk, David A.
Shaw, Leslie M.
Morris, John C.
Trojanowski, John Q.
Fagan, Anne M.
Arnold, Steven E.
Hu, William T. http://orcid.org/0000-0003-4862-6777
-
Funding
Funding for this research was provided by:
National Institute on Aging (43885, 42856, 25688, 10124, 17586, 05681, 26276, 03991, 016976)
- License Information
-
More Information
Article History
Received: 14 May 2018
Accepted: 3 September 2018
First Online: 25 September 2018
Ethics approval and consent to participate
: This study was approved by Institutional Review Boards at Emory University, University of Pennsylvania, and Washington University. All participants previously consented to CSF storage and analysis of stored CSF samples.
: Not applicable.
: LMS has received personal compensation for activities with Roche Diagnostics which produces CSF amyloid and tau assays. AMF is on the Scientific Advisory Boards for Roche Diagnostics which produces CSF amyloid and tau assays. WTH consults for ViveBio, LLC., which manufactures lumbar puncture trays; has a patent (assignee: Emory University) on the use of CSF p/t-Tau ratio in the evaluation of FTLD; has received research support from Fujirebio USA and Avid Pharmaceuticals; has received travel support from Hoffman La Roche and Abbvie. The remaining authors declare that they have no competing interests,
: Springer Nature remains neutral with regard to jurisdictional claims in published maps and institutional affiliations.
